OrthoXel Announces New Chairman & Non-Executive Director of Board

OrthoXel is excited to announce the appointment of two industry veterans to the board.  Gerry McDonnell  and Aidan O’Driscoll .

Gerry has joined OrthoXel as Chairman of the Board.  Gerry’s wealth of experience and industry knowledge from companies such as Stryker and DJO Global will be a key element in guiding OrthoXel  through commercial roll out and scaling.

Gerry McDonnell, “OrthoXel stood out to me as a serious opportunity to utilize my experience because of the outstanding innovation they have brought to the field of intramedullary nailing for orthopaedic trauma.  My years of experience will be brought to shape and guide the expansion of OrthoXel through 2021 and I am excited to be working with the great team they have established.

Aidan’s addition to the board brings extensive commercial experience from a financial and sales perspective within the Life Sciences and Technology sector.  Aidan has significant experience, with regards to funding of early and growth stage medical device technology companies, which will be a key ingredient for the success of OrthoXel’s growth strategy.

Aidan O’Driscoll, “The life science industry in Ireland is experiencing huge growth with Foreign Direct Investment continuing to expand despite current market challenges.  OrthoXel is uniquely positioned to take advantage of the current environment with a focus and foothold already on the lucrative United States market.  I am looking forward to supporting OrthoXel in the next phase of their growth and development.”

Pat O’Connor CEO OrthoXel, “I am delighted to have Gerry and Aidan join our board and I look forward to their guidance as we move the company through the next stages of growth.”